$1.48
0[0.00%]
At close: Apr 24
$1.48
0[0.00%]
PreMarket: 7:31PM EDT
Compass Therapeutics
(NASDAQ:CMPX)Compass Therapeutics Stock (NASDAQ:CMPX), Quotes and News Summary
Compass Therapeutics Stock (NASDAQ: CMPX) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 1.000 / 368.172K |
| Day Range | - - - |
| 52 Wk Range | 1.150 - 3.620 |
| Market Cap | $203.632M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 35 |
| Short Interest | 1.6% |
| Days to Cover | 5.02 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Compass Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary ant...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Compass Therapeutics (CMPX) stock?
You can purchase shares of Compass Therapeutics (NASDAQ: CMPX) through any online brokerage.
Who are Compass Therapeutics's (CMPX) competitors?
Other companies in Compass Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).
What is the target price for Compass Therapeutics (CMPX) stock?
The latest price target for Compass Therapeutics (NASDAQ: CMPX) was reported by HC Wainwright & Co. on Tuesday, April 16, 2024. The analyst firm set a price target for 10.00 expecting CMPX to rise to within 12 months (a possible 575.68% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Compass Therapeutics (CMPX)?
The stock price for Compass Therapeutics (NASDAQ: CMPX) is $1.48 last updated April 24, 2024 at 7:31 PM EDT.
Does Compass Therapeutics (CMPX) pay a dividend?
There are no upcoming dividends for Compass Therapeutics.
When is Compass Therapeutics (NASDAQ:CMPX) reporting earnings?
Compass Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
Is Compass Therapeutics (CMPX) going to split?
There is no upcoming split for Compass Therapeutics.
What sector and industry does Compass Therapeutics (CMPX) operate in?
Compass Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.